These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33409135)

  • 1. Several issues regarding the diagnostic imaging of medication-related osteonecrosis of the jaw.
    Kim JE; Yoo S; Choi SC
    Imaging Sci Dent; 2020 Dec; 50(4):273-279. PubMed ID: 33409135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
    Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
    Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.
    Muttanahally KS; Tadinada A
    Cureus; 2023 Aug; 15(8):e42830. PubMed ID: 37664344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
    Wongratwanich P; Shimabukuro K; Konishi M; Nagasaki T; Ohtsuka M; Suei Y; Nakamoto T; Verdonschot RG; Kanesaki T; Sutthiprapaporn P; Kakimoto N
    Dentomaxillofac Radiol; 2021 Sep; 50(6):20200417. PubMed ID: 33411572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the jaw: Case series and literature review.
    Kimathi D; Butt F; Guthua S; Waweru W
    Clin Case Rep; 2024 Apr; 12(4):e8788. PubMed ID: 38645603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication).
    Baba A; Ojiri H; Goto TK; Ikeda K; Yamauchi H; Ogino N; Mogami T
    Jpn Dent Sci Rev; 2019 Nov; 55(1):58-64. PubMed ID: 30815046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can dental panoramic radiographic findings serve as indicators for the development of medication-related osteonecrosis of the jaw?
    Klingelhöffer C; Klingelhöffer M; Müller S; Ettl T; Wahlmann U
    Dentomaxillofac Radiol; 2016; 45(5):20160065. PubMed ID: 27213837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.
    On SW; Cho SW; Byun SH; Yang BE
    Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33925361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review.
    Sakkas A; Heil S; Kargus S; Rebel M; Mischkowski RA; Thiele OC
    GMS Interdiscip Plast Reconstr Surg DGPW; 2021; 10():Doc03. PubMed ID: 33928006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication related osteonecrosis of the jaw in osteoporotic
    Walton K; Grogan TR; Eshaghzadeh E; Hadaya D; Elashoff DA; Aghaloo TL; Tetradis S
    Dentomaxillofac Radiol; 2019 Jan; 48(1):20180128. PubMed ID: 29952657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulation.
    Şahin O; Odabaşı O; Aliyev T; Tatar B
    J Korean Assoc Oral Maxillofac Surg; 2019 Apr; 45(2):108-115. PubMed ID: 31106139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cone Beam Computed Tomography (CBCT) in the Diagnosis and Clinical Management of Medication-Related Osteonecrosis of the Jaw (MRONJ).
    Ko YY; Yang WF; Leung YY
    Diagnostics (Basel); 2024 Aug; 14(16):. PubMed ID: 39202187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Antiangiogenic Agents to the Risk of Medication-related Osteonecrosis of the Jaw in Combination with Antiresorptive Agents: Preliminary Results in a Comparative Prospective Report of 59 Oncologic Cases.
    Yanni A; Bouland C; Monteiro R; Rodriguez A; Loeb I; Javadian R; Dequanter D
    J Int Soc Prev Community Dent; 2022; 12(5):564-570. PubMed ID: 36532328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.
    Iwata E; Akashi M; Kishimoto M; Kusumoto J; Hasegawa T; Furudoi S; Komori T
    Kobe J Med Sci; 2017 Feb; 62(5):E114-E119. PubMed ID: 28289268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Watanabe S; Nakajima K; Kinuya S
    Jpn Dent Sci Rev; 2019 Nov; 55(1):76-79. PubMed ID: 30956739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.